Delivery Order SPE2DB24D1205-SPE2DB25FCZNP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,417.24 to AmerisourceBergen Drug Corp for the supply of Promacta 12.5 mg tablets (30-count units) with an ultimate completion date of September 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $26,503.50 to AmerisourceBergen Drug Corp for the supply of Promacta 12.5 mg tablets in quantities of 30 units. This firm fixed price contract, awarded on May 22, 2025, with an ultimate completion date of June 13, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $48,118.52 delivery order to AmerisourceBergen Drug Corp for the supply of Promacta 75 mg tablets (30-count units) with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,026.53 to AmerisourceBergen Drug Corp for the supply of Promacta 50 mg tablets in quantities of 30 units. This non-competitive, firm fixed price delivery order was awarded on August 18, 2025, with an ultimate completion date of September 9, 2025. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $12,029.63 to supply Promacta 75 mg tablets (30-count units) with a completion deadline of May 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on April 24, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,088.89 to AmerisourceBergen Drug Corp for the supply of Promacta 75 mg tablets (30-tablet units) under a firm fixed price contract. The award, announced on September 19, 2025, with an ultimate completion date of October 10, 2025, represents a non-set-aside competitive procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a $4,418.06 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Promacta 25 mg tablets in quantities of 30 units. This is a firm fixed price contract with no set-aside designation, utilizing competitive procurement procedures. The contract is scheduled for ultimate completion on June 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $4,418.06 to AmerisourceBergen Drug Corp for Promacta 25 mg tablets (30-count units) on May 12, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside delivery order has a ceiling value of $8,026.53 with a firm fixed price structure and an ultimate completion date of September 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $8,026.53 and an ultimate completion date of September 17, 2025. The contract involves no set-aside designation and was competitively awarded. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania serves as both the place of performance...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZNPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,418.06 to AmerisourceBergen Drug Corp for the supply of Promacta 25 mg tablets in quantities of 30 units. This competitive, non-set-aside contract carries a firm fixed price structure and a completion date of September 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle extending through December 2026. The IDC enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and the U.S. Coast Guard. AmerisourceBergen's consistent track record of competitively awarded delivery orders across multiple therapeutic domains demonstrates its capability to fulfill federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 8/14/25 |